PLAY PODCASTS
Beyond Viral Suppression: What’s New in HIV Care for Treatment-Experienced People
Episode 486

Beyond Viral Suppression: What’s New in HIV Care for Treatment-Experienced People

Listen as study authors, Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH, explore the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.

Decera Clinical Education Infectious Disease Podcast · Princy Kumar MD MACP FRCP, Charlotte-Paige Rolle MD MPH

January 15, 202627m 49s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Tune in as Princy N. Kumar, MD, MACP, FRCP, and Charlotte-Paige Rolle, MD, MPH discuss the latest in immune recovery, chronic inflammation, and more in the management of treatment-experienced people living with HIV.

Topics covered include:

  • Immunologic nonresponse
  • Theories around soluble gp120 and antibody-dependent cellular cytotoxicity
  • Latest data from BRIGHTE, RECOVER, and more
  • Future Directions

Presenters:

Princy N. Kumar, MD, MACP, FRCP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Vice Dean for Student Affairs
Georgetown University School of Medicine
Washington, DC

Charlotte-Paige Rolle, MD, MPH
Director of Research Operations
Orlando Immunology Center
Adjunct Assistant Professor of Global Health
Emory University Rollins School of Public Health
Atlanta, Georgia

Link to full program: 
https://bit.ly/4pEenZC

Get access to all of our new podcasts by subscribing on Apple Podcasts, Google Podcasts, or Spotify!


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

hiv immune recovery / cd4 recoveryrecover study immune non-respondersimmunologic non-responders hivfostemsavir cd4 increasehiv comorbidities despite suppressionart in advanced hiv diseaseoptimizing antiretroviral therapy (art)long-term outcomes in suppressed hivbrighte study fostemsavirlate viral responders fostemsavirlow cd4 count despite viral suppressioninflammation biomarkers hivhiv chronic inflammationheavily treatment-experienced hiv (hte hiv)brighte trial 7-year resultsantibody-dependent cellular cytotoxicity (adcc) hivsoluble gp120 hivcd4/cd8 ratio hiv outcomesimmune activation in hivmanagement of treatment-experienced hivlong-term fostemsavir safetyfostemsavir (fostemsavir hiv)beyond viral suppression hivnon-aids defining events hivfostemsavir attachment inhibitorsustained virologic response multidrug-resistant hivgp120 attachment inhibitor hivmultidrug-resistant hiv treatmenttreatment-experienced hiv carebystander killing cd4 hivcd4 count under 200 hiv riskcd4-induced non-neutralizing antibodies hiv